Pradžia › Kiaušidžių vėžys
Kiaušidžių vėžys klinikiniai tyrimai JAV ieško dalyvių
263 tyrimai dėl Kiaušidžių vėžys ieško dalyvių vietose visoje Jungtinėse Valstijose.
Miestai su daugiausia tyrimų
- Houston, TX89 tyrimai
- New York City, NY69 tyrimai
- Boston, MA61 tyrimas
- Los Angeles, CA50 tyrimai
- Nashville, TN49 tyrimai
- Arlington, VA46 tyrimai
- Philadelphia, PA44 tyrimai
- Columbus, OH39 tyrimai
- St. Louis, MO38 tyrimai
- Chicago, IL36 tyrimai
- San Antonio, TX31 tyrimas
- Cleveland, OH30 tyrimai
- Pittsburgh, PA30 tyrimai
- Seattle, WA30 tyrimai
- Atlanta, GA29 tyrimai
- Rochester, MN29 tyrimai
- Dallas, TX28 tyrimai
- Oklahoma City, OK28 tyrimai
- Queens, NY28 tyrimai
- Durham, NC27 tyrimai
- Portland, OR27 tyrimai
- Detroit, MI26 tyrimai
- Aurora, CO25 tyrimai
- Baldwin Park, CA25 tyrimai
- Minneapolis, MN24 tyrimai
- San Diego, CA24 tyrimai
- Grand Rapids, MI24 tyrimai
- Birmingham, AL23 tyrimai
- Washington, DC23 tyrimai
- Miami, FL23 tyrimai
- Orlando, FL22 tyrimai
- Baltimore, MD22 tyrimai
- New Haven, CT21 tyrimas
- Tampa, FL21 tyrimas
- Edison, NJ20 tyrimai
- Salt Lake City, UT19 tyrimai
- Cincinnati, OH19 tyrimai
- Mountain View, CA19 tyrimai
- San Francisco, CA19 tyrimai
- Milwaukee, WI17 tyrimai
Pagal valstiją
- Aidahas4 tyrimai
- Ajova10 tyrimai
- Alabama27 tyrimai
- Aliaska7 tyrimai
- Arizona26 tyrimai
- Arkansas11 tyrimai
- Delaveras5 tyrimai
- Džordžija35 tyrimai
- Florida81 tyrimas
- Havajai7 tyrimai
- Ilinoisas49 tyrimai
- Indianas23 tyrimai
- Kalifornija105 tyrimai
- Kanzasas10 tyrimai
- Kentukis25 tyrimai
- Koloradas44 tyrimai
- Kolumbijos apskritis7 tyrimai
- Konektikutas28 tyrimai
- Luiziana19 tyrimai
- Masčusetsas67 tyrimai
- Menas9 tyrimai
- Merilendas40 tyrimai
- Minesota53 tyrimai
- Misisipė6 tyrimai
- Misūris41 tyrimas
- Mičiganas50 tyrimai
- Montana10 tyrimai
- Naujoji Hampšyras4 tyrimai
- Nebraska15 tyrimai
- Nevada11 tyrimai
- New Jersey40 tyrimai
- New Mexico16 tyrimai
- New York96 tyrimai
- North Carolina44 tyrimai
- North Dakota7 tyrimai
- Ohio70 tyrimai
- Oklahoma31 tyrimas
- Oregon34 tyrimai
- Pennsylvania69 tyrimai
- Rhode Island16 tyrimai
- South Carolina17 tyrimai
- South Dakota16 tyrimai
- Tennessee55 tyrimai
- Texas122 tyrimai
- Utah29 tyrimai
- Virginia57 tyrimai
- Washington38 tyrimai
- West Virginia10 tyrimai
- Wisconsin29 tyrimai
Nesenai atnaujinti tyrimai
Oficialus tyrimo tekstas (anglų kalba)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Renkami dalyviai2 fazė
Visi amžiai · Visoms lytims · Atnaujinta 2026-10-02 · NCT05564377The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Renkami dalyviai1/2 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT04585750Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 2 iki 100 · Visoms lytims · Atnaujinta 2026-10-02 · NCT01950572Distance-Based Exercise to Preserve Function and Prevent Disability
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT07059884A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT06465069Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
Renkami dalyviai1 fazė
Amžius nuo 18 iki 120 · Visoms lytims · Atnaujinta 2026-10-02 · NCT04847063Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Renkami dalyviai1 fazė
Amžius nuo 18 iki 120 · Visoms lytims · Atnaujinta 2026-10-02 · NCT06885697A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT06270706Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Renkami dalyviaiStebimasis tyrimas
Amžius 3 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT01441089Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Renkami dalyviai2 fazė
Amžius nuo 18 iki 72 · Visoms lytims · Atnaujinta 2026-10-02 · NCT01174121A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT06760819A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Renkami dalyviai1 fazė
Amžius 19 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT06586957A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Moterims · Atnaujinta 2026-10-01 · NCT07024784A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT06172478177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT07189871TLR9 Immunotherapy for Peritoneal Carcinomatosis
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT07658196Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian Cancer
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Moterims · Atnaujinta 2026-10-01 · NCT07851025Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT04751435The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07285044A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07278336A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07814248Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-29 · NCT07360314First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-29 · NCT06799065A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-29 · NCT05877599A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Moterims · Atnaujinta 2026-09-29 · NCT05128825Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.